Intracranial Atherosclerotic Disease

Stroke. 2019 May;50(5):1286-1293. doi: 10.1161/STROKEAHA.118.024147.

Authors

Shadi Yaghi^{1

2}, Shyam Prabhakaran³, Pooja Khatri⁴, David S Liebeskind⁵

Affiliations

¹ From the Department of Neurology, New York University, Brooklyn (S.Y.).
² Department of Neurology, The Warren Alpert Medical School of Brown University, Providence, RI (S.Y.).
³ Department of Neurology, University of Chicago, IL (S.P.).
⁴ Department of Neurology, University of Cincinnati, OH (P.K.).
⁵ Department of Neurology, Neurovascular Imaging Research Core and UCLA Stroke Center, University of California at Los Angeles (D.S.L.).

PMID: 31009344
DOI: 10.1161/STROKEAHA.118.024147

No abstract available

Keywords: adiponectin; autopsy; diabetes mellitus; hypertension; perfusion.

Publication types

Editorial

MeSH terms

Fibrinolytic Agents / therapeutic use
Humans
Intracranial Arteriosclerosis / diagnostic imaging*
Intracranial Arteriosclerosis / epidemiology*
Intracranial Arteriosclerosis / therapy
Stents

Substances

Fibrinolytic Agents